An osteoporosis medication used to protect aging bones may have another unexpected benefit: a lower risk of dementia.
Researchers at the University of Hong Kong found that older adults taking nitrogen-containing bisphosphonates had a 24% lower risk of Alzheimer’s disease and related dementias compared with patients using other osteoporosis medications. The findings, recently highlighted by ScienceDaily , raise an intriguing possibility for millions of adults concerned about memory loss.
Related: Ozempic-Friendly Foods Are Taking Over Grocery Stores, but There’s a Catch
Next: How Your Brain Activity Could Signal Alzheimer’s Risk Before You Feel Any Symptoms
Why These Bone Drugs Caught Researchers’ Attention
The study, published in Alzheimer’s & Dementia , examined medical records from 121,492 Hong Kong residents ages 60 and older who had osteoporosis or fragility fractures.
Patients taking nitrogen-containing bisphosphonates, including medications such as alendronate and zoledronate, had a 16% lower…